A Phase II Study of BVD-523 in Metastatic Uveal Melanoma
Clinical trial NCT03417739 · TERMINATED
Trial details
- NCT number
- NCT03417739
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-26
- Primary completion
- 2020-05-05
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.